Esperion Therapeutics
ESPR
#6091
Rank
A$1.40 B
Marketcap
A$5.94
Share price
3.42%
Change (1 day)
69.65%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.76. In 2024 the company made an earnings per share (EPS) of A-$0.35 an increase over its 2023 EPS that were of A-$3.21.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79125.95%
2024A-$0.35-89.15%
2023A-$3.21-40.28%
2022A-$5.37-62.87%
2021A-$14.4580.38%
2020A-$8.0150.14%
2019A-$5.34-53.18%
2018A-$11.407.41%
2017A-$10.61110.81%
2016A-$5.0347.35%
2015A-$3.420.89%
2014A-$3.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
A-$8.98 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.11-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.60-444.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$65.68-8,788.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.17-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.29-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA